Omicron variant spurs New York officials to recommend masking indoors
Nov 30, 2021
So far, there are no confirmed cases of the omicron variant in New York City, according to the health commissioner.
Biden pushes vaccines, masks as best defense against omicron variant
Nov 29, 2021
News reports out of South Africa noted that COVID-19 cases from omicron have resulted in mostly mild symptoms.
Vaccine makers already testing their shots against omicron variant
Nov 29, 2021
So far, existing vaccines have proven effective against prior coronavirus variants, including the delta variant.
Thanksgiving weekend brought new COVID-19 concerns: the omicron variant
Nov 29, 2021
Saturday, the CDC issued a statement stressing that “no cases of this variant have been identified in the U.S. to date.”
Moderna asks FDA to approve its booster shot for all adults
Nov 18, 2021
The Moderna booster is half the dose of the initial vaccination series: 50 mcg versus 100 mcg.
Pfizer asks FDA to approve booster shots for all U.S. adults
Nov 10, 2021
With its application, the company included early results of a study that involved 10,000 people.
White House takes more steps to up supply of rapid at-home COVID-19 tests
Oct 26, 2021
Tests will be be particularly useful during flu season because the tests can help distinguish between the flu and COVID-19.
Flu cases already up 23 percent this season: Walgreens
Oct 20, 2021
The significant increase shown by the company’s analysis of its own data reflects the historically low levels of flu last year as people stayed home, wore masks and got a record number of flu shots...
Potential safety concern for Guillain-Barré syndrome ID’d for Ad26.COV2.S
Oct 18, 2021
Receipt of the Ad26.COV2.S (Janssen/Johnson & Johnson) COVID-19 vaccine is associated with a potential small, but statistically significant, safety concern for Guillain-Barré syndrome (GBS), according...
FDA panel recommends approval of Johnson & Johnson booster shot
Oct 15, 2021
The booster shot is recommended for anyone 18 years and older, to be given at least two months after the first dose.